Edition:
United States

People: Home Depot Inc (HD.N)

HD.N on New York Stock Exchange

151.31USD
23 Jun 2017
Change (% chg)

$-4.17 (-2.68%)
Prev Close
$155.48
Open
$155.12
Day's High
$155.23
Day's Low
$150.92
Volume
3,318,431
Avg. Vol
1,275,467
52-wk High
$160.83
52-wk Low
$119.20

Katen, Karen 

Ms. Karen L. Katen is Independent Director of Company. She began her career at Pfizer Inc., a global pharmaceutical company, in 1974 and held a series of management positions with increasing responsibility, including President of Pfizer Global Pharmaceuticals and Executive Vice President of Pfizer Inc. from 2001 to 2005 and President of Pfizer Human Health from 2005 to 2007. She retired in 2007 as Vice Chairman of Pfizer. Currently, Ms. Katen serves as Senior Advisor of Essex Woodlands Health Ventures, a healthcare venture capital firm which she joined in 2007. Ms. Katen is also a director of Air Liquide, an international leader in gases for industry, health and the environment. She serves or has served with several healthcare-related organizations, including as chair of the RAND Corporation’s Health Board of Advisors, chair of ARMGO Pharma, Inc.’s Board of Directors, and as a member of the Takeda Global Advisory Board. She is also on the Board of Trustees of the University of Chicago. Ms. Katen has also served on a variety of international policy bodies, including as Chairman of the U.S.-Japan Business Council. Ms. Katen enhances our Board’s understanding of international, supply chain and marketing matters, with her expertise in those areas gained through her long and successful career at Pfizer and experience with other healthcare-related organizations. Her background also provides insight into healthcare issues. In addition, Ms. Katen’s service on a number of public and private company boards provides valuable insights into corporate management and board dynamics.

Basic Compensation

Total Annual Compensation, USD 50,000
Restricted Stock Awards, USD 230,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 280,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Craig Menear

11,471,600

Carol Tome

6,243,440

Matthew Carey

3,682,080

Teresa Roseborough

--

Timothy Crow

3,237,420

Ann-Marie Campbell

3,910,290
As Of  28 Jan 2017